Spin-out unveils world-leading technology to speed up drug discovery
A new 3D bio-printer that produces human-like tissue holds the potential to revolutionise the discovery of new drugs for cancer, heart disease and arthritis. Scientists from Newcastle University, with funding from Versus Arthritis, have developed a unique approach to bioprinting cell-filled gels. Their approach can closely mimic human tissues, earning it a patent in the […]
Newcastle spinout partners with leading innovator for eco-friendly textile dyeing
GitLife Biotech, a Newcastle University spinout pioneer in genetic tracking solutions, has partnered with Colorifix, a leading innovator in sustainable dye production. The partnership aims to enhance traceability and scalability in eco-friendly textile dyeing. Supported by Innovate UK, this collaboration investigates integrating advanced genetic barcoding into Colorifix’s dye manufacturing processes, enabling secure and efficient deployment […]
Prestigious fellowship for Newcastle academic entrepreneur and battery recycling spinout
Newcastle University’s Dr Mahfuz Kamal has been awarded an Enterprise Fellowship by the Royal Academy of Engineering to support him as CEO of spinout company RecoVolt. RecoVolt is a Newcastle University spinout company commercialising an innovative battery discharge system. The system is used with lithium-ion batteries at their end-of-life to ready them for battery recycling. […]
The Newcastle spinout helping to reduce the energy needs and carbon footprint of wastewater treatment
METzero Technologies, a Newcastle University and Northern Accelerator-supported spinout, is part of a new project aiming to reduce energy needs and carbon footprint in wastewater treatment. The METREAU project will see the first use of microbial electrochemical technologies at a commercial scale for wastewater treatment. Northumbrian Water is leading the project, with partners at Newcastle […]
Newcastle spinout Microbritt raises £400k to scale up unique business
Newcastle University spinout, Microbritt, has raised £400,000 to scale its production capacity. The investment will also enable the company to expand their sales and engineering team and invest in R&D. The investment round was led by the North East Innovation Fund supported by the European Regional Development Fund and managed by Northstar Ventures, alongside Business […]
Record year of investment for Newcastle University spinouts
Newcastle University marked a record year in 2023 as investments in spin-out across life sciences, sustainable engineering and digital tech totalled over £40m. Created from research discoveries, the University’s 37 active spin-out companies now employ over 300 people. Spearheading the investment surge is Advanced Electric Machines who completed a £23M fund raising round. The funding […]
In the press: Newcastle spinout creating more jobs at new city centre base
Newcastle University spinout Aelius Biotech has raised £1.25m investment from the North East Venture Fund. The company now plans to open new lab facilities in the city centre. Aelius Biotech provides testing services for pharmaceutical and nutrition companies, using a model of a human gut to trial new drugs without the use of animals. The […]
In the press: CellRev secures £1.4m for scale up
A Newcastle University spinout has secured investment of £1.4m from the North East Innovation Fund and Innovate UK. CellRev spun out in 2019 and was the brainchild of academic founders Dr Martina Miotto and Professor Che Connon. The company focuses on technologies for the continuous manufacture of adherent cells. Their work is applicable in the […]
In the press: North East Times speaks to three promising spin-outs
North East Times magazine’s September issue shines a light on three of Northern Accelerator’s latest spin-out companies from Newcastle and Durham Universities. Skin Life Analytics, ESP Diagnostics and Respiratone were supported by Northern Accelerator to spin-out of the region’s universities recently, utilising our Executives into Business programme and other support to ensure the best chance […]
AMLo Biosciences raises £2.45m to further develop early stage skin cancer test
AMLo Biosciences Ltd (AMLo), an innovative medical device company spun out of Newcastle University specialising in the early detection of skin cancers, has secured significant further investment totalling £2.45m. At present all early stage melanomas are treated in a similar way, sometimes involving invasive surveillance diagnostics designed to identify the few high-risk melanomas at the […]
